These effects, along with a past report showing that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like behavior in mice,two aid the concept of concentrating on ACKR3 as a novel strategy to modulate the opioid technique, which could open new therapeutic avenues for opioid-related Issu